María Larrosa-García

6PUBLICATIONS
18CO-AUTHORS
AllergyCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Infant and child healthPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 22, 2026
Impact of FCGR2A and FCGR3A Gene Variants on the Response to Rituximab in Patients With Glomerular Diseases.

|Oct 08, 2025
Higher ustekinumab concentrations in induction are associated with better endoscopic outcomes in inflammatory bowel disease.

Xavier Serra-Ruiz, Elena Céspedes-Martínez, Luis Mayorga

|Jun 27, 2025
Pharmacokinetic Characterization of Rituximab in Patients with Glomerular Diseases.

María Larrosa-García, Irene Agraz Pamplona, María Teresa Sanz Martínez

|Jan 08, 2025
Long-Term Effectiveness and Safety of Proactive Therapeutic Drug Monitoring of Infliximab in Paediatric Inflammatory Bowel Disease: A Real-World Study.

Susana Clemente Bautista, Óscar Segarra Cantón, Núria Padullés-Zamora

|Jun 26, 2021
Long-term effects of COVID-19 in solid organ transplantation recipients.

Maria Larrosa-Garcia, Sonia Garcia-Garcia, Ibai Los-Arcos

|Feb 04, 2021
Long-term effectiveness of an intervention to enhance mirabegron use revision and its deprescribing: 36-month follow-up of a quasi-experimental trial in primary care.

Eladio Fernández-Liz, Pere Vivó-Tristante, Antonio Aranzana-Martínez

Pageof 1

Frequent Collaborators

3 joint publications

Sonia Garcia-Garcia

2 joint publications

Maria Queralt Gorgas Torner

2 joint publications

Marta Miarons

1 joint publications

Susana Clemente Bautista